Net Cash Provided by (Used in) Operating Activities |
-600K |
USD |
+14.3% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-200K |
USD |
|
Q1 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
50K |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
28.1K |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-600K |
USD |
+33.3% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.2M |
USD |
-70.7% |
Q4 2022 |
FY 2022 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
100K |
USD |
-50% |
Q1 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
148M |
USD |
-5.79% |
Q4 2022 |
FY 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
148M |
USD |
-5.79% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
64.3M |
USD |
-11.8% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Authorized |
200K |
shares |
0% |
Q2 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
200K |
USD |
0% |
Q4 2022 |
FY 2022 |
Additional Paid in Capital |
1.07B |
USD |
0% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Interest Expense |
100K |
USD |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |